← Back to Search

Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

N/A
Recruiting
Led By Benjamin D Smith, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of surgery
Awards & highlights
No Placebo-Only Group

Summary

This study evaluates the skin and surrounding soft tissue that is removed during an implant reconstruction after a mastectomy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nanomechanical properties of the skin and adjacent soft tissue

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo tissue collection during standard of care surgery, have their medical records reviewed, and complete questionnaires throughout the study.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,071 Previous Clinical Trials
1,803,120 Total Patients Enrolled
147 Trials studying Breast Cancer
63,203 Patients Enrolled for Breast Cancer
ArtidisIndustry Sponsor
4 Previous Clinical Trials
488 Total Patients Enrolled
1 Trials studying Breast Cancer
126 Patients Enrolled for Breast Cancer
Benjamin D Smith, MDPrincipal InvestigatorM.D. Anderson Cancer Center
~38 spots leftby Aug 2025